Praxis will receive an upfront payment from UCB, and if the option is exercised by UCB, would be eligible to receive an option fee and future success-based development and commercialization milestone payments, for a total of up to ~$100M, in addition to tiered royalties on net sales of any resulting products from the collaboration.
Stock up 2.3% after-hours.
Effectively over $2.5 trillion in investor wealth has been worn out over the previous week if one considers the key...
The markets traded with a transparent detrimental bias by the week, witnessing persistent promoting stress and ending the interval on...
Cited by Barron's as one of many high monetary web sites to go to on the weekend, Monetary Sense (www.financialsense.com)...
A Sri Lanka Navy vessel approaches an Iranian vessel throughout a rescue operation, a day after the crew of a...
Shares of PB Fintech, the mother or father firm of Policybazaar, noticed massive block offers value about Rs 695 crore...
This text was written byObserveIn search of Alpha's transcripts group is answerable for the event of all of our transcript-related...
Get the latest news and follow the coverage of Business & Financial News, Stock Market Updates, Analysis, and more from the trusted sources.
